US Regulatory Trends During 2010: A Rapidly Changing EnvironmentBusiness Monitor International
January 21, 2011
28 Pages - SKU: BMI6169372
More Regulation & Policy reports by Business Monitor International
Central America Pharmaceuticals and Healthcare Report Q1 2013 by Business Monitor International
BMI View: The political instability and underdeveloped economies in many Central American countriesmake the region less attractive to multinationals, compared with most neighbouring countries. However,the ...
Turkey Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: Our view is that, as one of the world's major emerging economies, Turkey will continue to attract international investment across many industries. However, ...
Tanzania Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: Patients and domestic drugmakers will be encouraged by the Tanzanian government's focus on the local production of antiretroviral (ARV) medicines, particularly as it ...
Pakistan Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor InternationalSee all reports like this >>
BMI View: The operational environment for drugmakers in Pakistan has worsened over the past year, partly as a result of the dissolution of the Ministry ...
More United States Regulation & Policy reports
Contract Research Organizations in the US - Industry Market Research Report by IBISWorld
Contract Research OrganizationsThe industry experienced aggressive growth during the past five years as operators have worked to provide clients with a full-service experience, from product ...
Early Toxicology: Markets and Approaches by Kalorama Information
Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the ...
Freedonia Focus on Healthcare Overview: United States by Freedonia Focus Reports
This report discusses US healthcare for the years 2006 and 2011, with forecasts for 2016. Topics covered include market size, expenditure and medical provider segmentation, ...
How Have Zyprexa’s Patent Expiry, the Launch of Novel Atypical Antipsychotics, and Payer Decisions Reshaped U.S. Physician Behaviors in the Major Psychiatry Markets? by Decision ResourcesSee all reports like this >>
This U.S. Physician and Payer Forum explores payer and physician dynamics that affect prescribing practices for atypical antipsychotics for schizophrenia, bipolar disorder, ...
More United States reports
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
The 2013-2018 Outlook for Indian Breads in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for Indian breads across the states and cities of the United States. Latent demand (in millions of ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.See all reports like this >>
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
Regulation & Policy Reports
- South Korea Pharmaceutical Market Outlook 2013
- Russian Pharma Industry In Details
- Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players
- Perspective: StudyOptimizer — Empowering Clinical Trial Enrollment Collaboration at Big Pharma
- Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players